✦ LIBER ✦

Pharmacokinetics of trospectomycin sulphate in healthy subjects after single intravenous and intramuscular doses.

✍ Scribed by DJ Nichols; A Bye; E Novak

Book ID: 117945135
Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 483 KB
Volume: 32
Category: Article
ISSN: 0306-5251
DOI: 10.1111/j.1365-2125.1991.tb03893.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of eltoprazine in healt

Pharmacokinetics of eltoprazine in healthy male subjects after single dose oral and intravenous administration.

✍ M. Raghoebar; M. Mak; A. Cournot; MC Pistorius; J. Van Harten; H. Roseboom 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 643 KB

Pharmacokinetics of esomeprazole after o

Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects

✍ ; ; ; 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 108 KB

Pharmacokinetics of esomeprazole after o

Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects

✍ Mohammed Hassan-Alin; Kerstin Rohss; Tommy Andersson; Lars Nyman 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 186 KB

Pharmacokinetics of lansoprazole and its

Pharmacokinetics of lansoprazole and its main metabolites after single and multiple intravenous doses in healthy Chinese subjects

✍ Dan Zhang, Yanan Zhang, Man Liu… 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 271 KB

The pharmacokinetics of intravenous, int

The pharmacokinetics of intravenous, intramuscular, and subcutaneous nalbuphine in healthy subjects

✍ M. W. Lo; F. H. Lee; W. L. Schary; C. C. Whitney 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 476 KB

Single intravenous dose and steady-state

Single intravenous dose and steady-state oral dose pharmacokinetics of nicardipine in healthy subjects

✍ John G. Wagner; Teck L. Ling; Edward J. Mroszczak; Donna Freedman; Ann Wu; Bee H 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 617 KB

Nicardipine HCI oral doses (10-40 mg) were administered sequentially to six healthy subjects. For each regimen the capsule dose was administered every 8 hours (q 8 h) for 3 days and the plasma profiles of nicardipine and its pyridine analogue (M5) were determined following the last dose on day 4. St